本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Taysha Gene Therapies, Inc.

4.55
-0.1000-2.15%
盤後4.570.0200+0.44%18:47 EST
成交量:209.97萬
成交額:960.20萬
市值:12.46億
市盈率:-13.54
高:4.80
開:4.69
低:4.45
收:4.65
52周最高:6.02
52周最低:1.05
股本:2.74億
流通股本:1.84億
量比:0.89
換手率:1.14%
股息:- -
股息率:- -
每股收益(TTM):-0.3359
每股收益(LYR):-0.3570
淨資產收益率:-64.93%
總資產收益率:-25.70%
市淨率:5.69
市盈率(LYR):-12.75

資料載入中...

2026/02/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/06

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/11/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/04

重要事件披露

Form 8-K - Current report
2025/11/04

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/17

重要事件披露

Form 8-K - Current report
2025/10/09

重要事件披露

Form 8-K - Current report
2025/10/02

重要事件披露

Form 8-K - Current report